Publications by authors named "Alessandro Carugo"

26Publications

The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?

Cancers (Basel) 2019 Oct 16;11(10). Epub 2019 Oct 16.

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.

View Article and Find Full Text PDF
October 2019

Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational Research.

Cancers (Basel) 2019 Sep 6;11(9). Epub 2019 Sep 6.

Department of Genomic Medicine, UT MD Anderson cancer center, Houston, TX 77054, USA.

View Article and Find Full Text PDF
September 2019

Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next?

Oncotarget 2019 Jun 18;10(40):3979-3981. Epub 2019 Jun 18.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article and Find Full Text PDF
June 2019

Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer.

Cancers (Basel) 2019 Apr 2;11(4). Epub 2019 Apr 2.

Department of Thoracic/Head & Neck Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article and Find Full Text PDF
April 2019

p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.

Cancer Cell 2019 02;35(2):204-220.e9

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article and Find Full Text PDF
February 2019

Collapsing the Tumor Ecosystem: Preventing Adaptive Response to Treatment by Inhibiting Transcription.

Cancer Discov 2018 01;8(1):17-19

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
January 2018

Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer.

Cancer Res 2015 Mar 3;75(6):1091-101. Epub 2015 Mar 3.

Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
March 2015